Skip to main content

Table 1 Clinical Characteristics of Subjects with JIA

From: Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing

 

J-11

J-12

J-13

J-14

J-15

J-17

Sex

F

F

M

F

F

F

Race

White

White

White

White

Asian

Asian

Age of onset

2

15

12

1

7

5

JIA category

Oligo

Poly

Oligo

Poly

Oligo

Oligo

Joint Count

1

18

2

17

1

1

Patient global assessment

4

9.5

4

4

1

2

Physician global assessment

3

6

6

9

2

2

CHAQ

1.12

2.30

0.25

2.12

0

2

JADAS-27

8

33.5

16.5

30.9

5

9

ANA

Negative

1:320

Negative

Negative

1:320

Negative

RF

ND

Negative

Negative

Negative

Negative

Negative

CCP status

Negative

 > 250

Negative

Negative

80

Negative

B27

ND

Negative

Negative

Negative

Negative

Negative

Medications

Naproxen

Naproxen

None

Allergy med*

None

None

  1. Subject J-12 also had a diagnosis of cerebral palsy. Subject J-13 developed Crohn disease several months after diagnosis of arthritis. Subjects J-11 and J-12 were on a nonsteroidal anti-inflammatory drug (Naproxen) at baseline, but none of the others were on any medication to treat their joint symptoms. None of the subjects had received glucocorticoid drugs. Subject J-14 reported being on albuterol inhalers and intranasal fluticasone
  2. Healthy control C14 was a 22-year-old non-Hispanic white female and C22 was a 25-year-old Asian female. Neither reported a history of autoimmune diseases or being on any medications at the time of participation